Novel delivery device for monolithical solid oral dosage forms for personalized medicine

International Journal of Pharmaceutics

Volumn 395, Issue 1-2, 2010, Pages 174-181

  Wening, Klaus ^a   Breitkreutz, Jörg ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Delivery device; Extrusion; Individual therapy; Personalized medicine; Sustained release

Indexed keywords

CARVEDILOL; DRUG CARRIER; ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAZOLE DERIVATIVE; DELAYED RELEASE FORMULATION; DRUG DOSAGE FORM; PROPANOLAMINE DERIVATIVE;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; CHEMISTRY; DELAYED RELEASE FORMULATION; DEVICES; DRUG DOSAGE FORM; EQUIPMENT DESIGN; FEASIBILITY STUDY; KINETICS; MEDICINAL CHEMISTRY; ORAL DRUG ADMINISTRATION; PERSONALIZED MEDICINE; PHARMACEUTICS; PROCEDURES; SOLUBILITY;

ADMINISTRATION, ORAL; ADRENERGIC ANTAGONISTS; CARBAZOLES; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DOSAGE FORMS; DRUG CARRIERS; DRUG COMPOUNDING; EQUIPMENT DESIGN; FEASIBILITY STUDIES; INDIVIDUALIZED MEDICINE; KINETICS; PROPANOLAMINES; SOLUBILITY; TECHNOLOGY, PHARMACEUTICAL;

EID: 77954313895     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.05.036     Document Type: Article

References (35)

1. Albers S., Meibohm B., Mir T.S., Läer S. Population pharmacokinetics and dose simulation of carvedilol in paediatric patients with congestive heart failure. Br. J. Clin. Pharmacol. 2008, 65:511-522.
2. Bauriegel L. Dosierspender für freifließendes, schuettfaehiges Pulver und partikelförmiges. Gut 2007, DE 200 23 931 U1 (in German).
3. Bredenberg S., Nyholm D., Aquilonius S.M., Nystram C. An automatic dose dispenser for microtablets-a new concept for individual dosage of drugs in tablet form. Int. J. Pharm. 2003, 261:137-146.
4. Breitkreutz, J., Wazlawik, L., 2005. Microdose Vorrichtung und Verfahren zur Dosierung einer frei waehlbaren Anzahl von stueckigen Festkoerpern. DE 102004001645 A1.
5. Brown D., Ford J.L., Nunn A.J., Rowe P.H. An assessment of dose-uniformity of samples delivered from paediatric oral droppers. J. Clin. Pharm. Ther. 2004, 29:521-529.
6. Cholerton S., Daly A.K., Idle J.R. The role of individual human cytochromes P450 in drug metabolism and clinical response. Trends Pharmacol. Sci. 1992, 13:434-439.
7. Dicke, S., 2008. Pharmazeutisch-technologische Untersuchungen zur Entwicklung von Theophyllin-Depotarzneiformen mit variabler Freisetzung. Dissertation. IPT Verlag, Muenster.
8. Giessmann T., Modess C., Hecker U., Zschiesche M., Dazert P., Kunert-Keil C., Warzok R., Engel G., Weitschies W., Cascorbi I., Kroemer H.K., Siegmund W. CYP2D6 genotype and induction of intestinal drug transporters by rifampicin predict presystemic clearance of carvedilol in healthy subjects. Clin. Pharmacol. Ther. 2004, 75:213-222.
9. Griessmann K., Breitkreutz J., Schubert-Zsilavecz M., Abdel-Tawab M. Dosing accuracy of measuring devices provided with antibiotic oral suspensions. Paediatr. Perinat. Drug Ther. 2007, 8:61-70.
10. Henderson L.S., Tenero D.M., Baidoo C.A., Campanile A.M., Harter A.H., Boyle D., Danoff T.M. Pharmacokinetic and pharmacodynamic comparison of controlled-release carvedilol and immediate-release carvedilol at steady state in patients with hypertension. Am. J. Cardiol. 2006, 98:17-26.
11. Ingelman-Sundberg M., Sim S.C., Gomez A., Rodriguez-Antona C. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. Pharmacol. Ther. 2007, 116:496-526.
12. Kayitare E., Vervaet C., Ntawukulilyayo J.D., Seminega B., Bortel V., Remon J.P. Development of fixed dose combination tablets containing zidovudine and lamivudine for paediatric applications. Int. J. Pharm. 2009, 370:41-46.
13. Kearns G.L., Abdel-Rahman S.M., Alander S.W., Blowey D.L., Leeder J.S., Kauffman R.E. Developmental pharmacology-drug disposition, action, and therapy in infants and children. N. Engl. J. Med. 2003, 349:1157-1167.
14. Keleb E.I., Vermeire A., Vervaet C., Remon J.P. Cold extrusion as a continuous single-step granulation and tabletting process. Eur. J. Pharm. Biopharm. 2001, 52:359-368.
15. Kircher W. Arzneiformen richtig anwenden, ergonomische Aspekte. Correct use of dosage forms, Ergonomic Aspects 2007, DAV, Stuttgart, pp. 17-29 (in German).
16. Knoll AG, 1999. Dosierloeffel für Mikrotabletten. DE 29907996 U1 (in German).
17. Korsmeyer R.W., Peppas N.A. Effect of the morphology of hydrophilic polymeric matrices on the diffusion and release of water soluble drugs. J. Membr. Sci. 1981, 9:211-227.
18. McDevitt J.T., Gurst A.H., Chen Y. Accuracy of tablet splitting. Pharmacotherapy 1998, 18:193-197.
19. Quinzler R., Gasse C., Schneider A., Kaufmann-Kolle P., Szecsenyi J., Haefeli W.E. The frequency of inappropriate tablet splitting in primary care. Eur. J. Clin. Pharmacol. 2006, 62:1065-1073.
20. Rodenhuis N., De Smet P.A.G.M., Barends D.M. The rationale of scored tablets as dosage form. Eur. J. Pharm. Sci. 2004, 21:305-308.
21. Ronca, R., 2007. Pharmaceutical single dosage form. EP 1923056 A1.
22. Rosenberg J.M., Nathan J.P., Plakogiannis F. Weight variability of pharmacist-dispensed split tablets. J. Am. Pharm. Assoc. 2002, 42:200-205.
23. Santos H., Veiga F.M., Pina E., Sousa J.J. Compaction, compression and drug release characteristics of xanthan gum pellets of different compositions. Eur. J. Pharm. Sci. 2004, 21:271-281.
24. Schomakers, J., Grummel, A., 2002. Dosing stick containing rod-shaped tablets, WO 02/102296 A1.
25. Schuster, W., 1988. Dosierspender. DE 3632546 A1 (in German).
26. Sobhani P., Christopherson J., Ambrose P.J., Corelli R.L. Accuracy of oral liquid measuring devices: comparison of dosing cup and oral dosing syringe. Ann. Pharmacother. 2008, 42:46-52.
27. Standing J.F., Tuleu C. Paediatric formulations-getting to the heart of the problem. Int. J. Pharm. 2005, 300:56-66.
28. Talukdar M.M., Michoel A., Rombaut P., Kinget R. Comparative study on xanthan gum and hydroxypropylmethyl cellulose as matrices for controlled-release drug delivery. I. Compaction and in vitro drug release behaviour. Int. J. Pharm. 1996, 129:233-324.
29. Talukdar M.M., Van den Mooter G., Augustijns P., Tjandra-Maga T., Verbeke N., Kinget R. In vivo evaluation of xanthan gum as a potential excipient for oral controlled release matrix tablet formulation. Int. J. Pharm. 1998, 169:105-113.
30. Teng J., Song C.K., Williams R.L., Polli J.E. Lack of medication dose uniformity in commonly split tablets. J. Am. Pharm. Assoc. 2002, 42:195-199.
31. Thomson S.A., Tuleu C., Wong I.C.K., Keady S., Pitt K.G., Sutcliffe A.G. Minitablets: new modality to deliver medicines to preschool-aged children. Pediatrics 2009, 123:235-238.
32. Van Santen E., Barends D.M., Frijlink H.W. Breaking of scored tablets: a review. Eur. J. Pharm. Biopharm. 2002, 53:139-145.
33. Weber M.A. Controlled-release carvedilol in the treatment of essential hypertension. Am. J. Cardiol. 2007, 99:430.
34. Wessel T., Breitkreutz J., Ahlke E., Hempel G., Boos J. Problems with mercaptopurine tablets in maintenance therapy. Krankenhauspharmazie 2001, 22:325-329.
35. Zhou S.F., Di Y.M., Chan E., Du Y.M., Chow V.D.W., Xue C.C., Lai X., Wang J.C., Li C.G., Tian M., Duan W. Clinical pharmacogenetics and potential application in personalized medicine. Curr. Drug Metab. 2008, 9:738-784.